# FDA Inspection 1277489 - LEK d.d. - October 02, 2024

Source: https://www.keypedia.com/records/fda_inspections/lek-dd/839e6048-5c7e-481d-8722-944d34d548d7
Source feed: FDA_Inspections

> FDA Inspection 1277489 for LEK d.d. on October 02, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277489
- Company Name: LEK d.d.
- Inspection Date: 2024-10-02
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277489 - 2024-10-02](https://www.keypedia.com/records/fda_inspections/lek-dd/b25597c0-284d-4c86-9c87-8672ac6a412e)
- [FDA Inspection 1123337 - 2019-03-14](https://www.keypedia.com/records/fda_inspections/lek-dd/d532f4ac-080b-4b61-9003-b15f9bcb8a38)
- [FDA Inspection 892528 - 2014-07-17](https://www.keypedia.com/records/fda_inspections/lek-dd/ac8aeb03-a4ba-413e-95a0-88ab922bc532)
- [FDA Inspection 785881 - 2012-05-17](https://www.keypedia.com/records/fda_inspections/lek-dd/c2e937b0-14d1-40ec-b925-66ae97bd7298)

Company: https://www.keypedia.com/companies/lek-dd/c0d31ce7-5f89-4795-8f41-03edc49e6e35

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c